Date: 2024/11/03 - 00:50
Mirikizumab, a drug currently approved by the Food and Drug Administration (FDA) for the treatment of ulcerative colitis, also sends Crohn's disease into clinical remission, new findings suggest.
Date: 2024/10/19 - 01:25
NIH-funded analysis suggests higher doses of buprenorphine were associated with lower rates of future behavioral health-related emergency department and inpatient care.